AzTrials
AzTrials

Carpal Tunnel SyndromeNCT06048861

Evaluation of Joint Position Sense in Carpal Tunnel Syndrome

A study testing KForce Sens and Baseline Electrıgoniometer in people with Carpal Tunnel Syndrome, run by Pamukkale University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of the study was to investigate the validity and reliability of the KForce Sens® for the evaluation of wrist joint position sense in individuals with CTS. Wrist joint position sense was assessed with KForce Sens® and Baseline® electrogoniometer. Read more about this study

Who is it for?
Ages 22 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Carpal Tunnel Syndrome
What is being tested?
KForce Sens and Baseline Electrıgoniometer
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
70 participants
Where
1 siteTurkey (Türkiye)
Study dates
20 Feb 2022to 4 Apr 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 22 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • mild to moderate CTS confirmed with EMG
  • having symptoms for at least 3 months
  • not receiving medical treatment and physiotherapy until 3 months before the study at the latest

Who cannot join

  • having trauma in the affected extremity in the last 6 months
  • having cervical radiculopathy
  • having brachial plexopathy
  • having cognitive problems
  • having neurological problems
  • being pregnant

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Pamukkale University

    Denizli

Other trials in Turkey (Türkiye)

About this study

Official title: Evaluation of Joint Position Sense With Two Different Electrogoniometers in Mild and Moderate Carpal Tunnel Syndrome

The aim of the study was to investigate the validity and reliability of the KForce Sens® for the evaluation of wrist joint position sense in individuals with CTS. Wrist joint position sense was assessed with KForce Sens® and Baseline® electrogoniometer. The validity and reliability of the KForce Sens® for wrist position sense evaluation were investigated by comparing the two data sets.

Being tested
KForce Sens, Baseline Electrıgoniometer
Keywords
joint position sense, electrogoniometer, carpal tunnel syndrome
Medical subject headings
Carpal Tunnel Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • KForce SensDevice

    The device was attached to the middle of the wrist joint with the help of Velcro for all movements. Starting position of the extremity was determined and this position was introduced to the device as the reference position. Then, the participant was asked to perform the movement.

  • Baseline ElectrıgoniometerDevice

    The pivot point of the goniometer was placed next to the ulnar styloid for 30° and 60° wrist flexion and extension, and also it was placed in the middle carpometacarpal joint for radial and ulnar deviation. A passive movement was made to the extremity in a predetermined amount and direction. The participant was asked to remember this position. Then, the participant was asked to return the extremity to this position when their eyes were closed.

Study groups in NCT06048861
Study groupRoleWhat they receive
Individuals with Carpal Tunnel SyndromeExperimentalNot described
Receives: Device: KForce Sens; Device: Baseline Electrıgoniometer
Healthy ControlsExperimentalNot described
Receives: Device: KForce Sens

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Joint position sense

    The evaluation of participants' wrist position sense was performed with a Baseline® electrogoniometer.

    Measured: Day 1

  2. Joint position test

    The evaluation of participants' wrist position sense was performed with a KForce Sens®.

    Measured: Day 1

  3. Joint position sense re-test

    The evaluation of participants' wrist position sense was performed with KForce Sens®.

    Measured: up to 1 week

Secondary outcomes (1)
  1. Function and symptom severity

    The Boston Carpal Tunnel Questionnaire included 11 items indicating the severity, frequency, and duration of symptoms, and the BCTQ-F includes 8 items indicating difficulty in performing daily tasks. Each item has five possible answers in Likert scale scored from 1 (never) to 5 (most severe). Mean values were calculated for all items in the BCTQ.

    Measured: Day 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Sep 2023
  2. Study start20 Feb 2022
  3. Primary completion4 Apr 2023
  4. Study completion4 Apr 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
70 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06048861
Sponsor's protocol ID
E-60116787-020-136447
Status last verified
Sep 2023
First submitted
7 Sep 2023
Last updated
20 May 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing KForce Sens and Baseline Electrıgoniometer in people with Carpal Tunnel Syndrome, run by Pamukkale University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Joint position sense (time frame: Day 1). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in